Employers & Consultants

Line Art 1
Line Art 2
Line Art 3
Line Art 4
As Seen In: Shortlister

Prescryptive tops Shortlister as #1 for PBM and Price Transparency

Shortlister has named Prescryptive Health with two honors in Q1 2024: #1 Vendor in Pharmacy Benefit Management (PBM)…

PBM satisfaction drops to new low. Is it time for a change?

A recent report shows PBM satisfaction at its lowest level since 2014. Here's how to find a Pharmacy…

As Seen In: BenefitsPRO

3 things to know about Specialty pharmacy in 2024

Specialty drug costs are expected to rise 15% in 2024. Employers need a plan in place for this…

As Seen In: Fierce Healthcare

2024 Outlook: Will legislators pass meaningful reforms to PBMs? The jury is still out

Heading into the new year, PBM legislation is a hot topic in the healthcare industry. Prescryptive CEO, Chris…

PODCAST: Biosimilars can help drive down medication costs. What you need to know.

An expert's perspective on helping more people get access to more affordable prescriptions.

Industry chatter: 7 of our favorite Prescryptive soundbites from 2023

Revisit some of the year’s most compelling conversations in healthcare and prescription technology

How biosimilars can help fix a broken prescription drug system

Biologic drugs revolutionized the way we treat many serious diseases. But there’s a downside. Biologics are produced using…

Why patient retention is the key to healthy connections

Health systems consistently seek new ways to effectively engage existing patients. Providers know that when patients are empowered to…

Prescryptive Health’s Patented Prescription Management Platform Now Available for PBMs and Employers

Providing real-time price transparency on a mobile phone at the point of care, myPrescryptive delivers plan and member…

myPrescryptive: 3 reasons why I believe in this healthcare technology

Hint: It’s all about the power of choice Looking back on my journey at the crossroads of technology…

Biosimilars: What are they and why do they matter?

It’s easy to see why biosimilars are a hot topic in healthcare. Not only are they a safe…

As Seen In: STAT News

‘It’s beyond unethical’: Opaque conflicts of interest permeate prescription drug benefits

This investigation by STAT News showed that there’s a hidden flow of money between major consulting firms and…